Interactions of forebrain cholinergic and somatostatinergic systems in the rat.
The neurochemical, behavioral and pharmacological effects of forebrain cholinergic and somatostatinergic deficits were assessed in adult rats. Brain somatostatinergic activity was manipulated by the systemic administration of different doses of cysteamine. Forebrain cholinergic systems were lesioned by the infusion of ibotenic acid into the nucleus basalis of Meynert (nbM). Forebrain cholinergic lesions did not affect forebrain somatostatin-like-immunoreactivity (SLI). Depletion of forebrain SLI by cysteamine did not significantly affect forebrain cholinergic marker activity. The combination of forebrain cholinergic deficits with forebrain somatostatinergic deficits did not lead to any greater impairment of mnemonic function than that produced by lesions alone, nor did SLI deficits hamper the efficacy of physostigmine to enhance memory in sham operated or nbM-lesioned rats. These results suggest that although forebrain cholinergic and somatostatinergic systems do interact at some levels, this interaction is a minor one with respect to neurochemical, behavioral or pharmacological variables.
Haroutunian
V
V
Mount Sinai School of Medicine, New York, NY.
Kanof
P D
PD
Davis
K L
KL
D000818:Animals; D001479:Basal Ganglia; D002799:Cholinergic Fibers / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D003543:Cysteamine / Q000494:pharmacology; D007051:Ibotenic Acid; D007858:Learning / Q000187:drug effects / Q000502:physiology*; D008297:Male; D010455:Peptides / Q000378:metabolism / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D013377:Substantia Innominata / Q000166:cytology* / Q000502:physiology
D010455:Peptides; C029993:somatostatin-like peptides; D007051:Ibotenic Acid; D003543:Cysteamine